Cargando…
Molecular docking based design of Dengue NS5 methyltransferase inhibitors
Dengue is a viral infection caused by RNA infection of the family Flaviviridae and spread by the Aedes mosquitoes. Dengue NS5 methyltransferase is a known drug target for the disease. Therefore, it is of interest to design potential inhibitors for the target using molecular docking analysis. Our ana...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614123/ https://www.ncbi.nlm.nih.gov/pubmed/31312076 http://dx.doi.org/10.6026/97320630015394 |
_version_ | 1783433128404058112 |
---|---|
author | Kausar, Mohd Adnan Ali, Abrar Qiblawi, Samir Shahid, SMA Izhari, Mohammad Asrar saral, Anamika |
author_facet | Kausar, Mohd Adnan Ali, Abrar Qiblawi, Samir Shahid, SMA Izhari, Mohammad Asrar saral, Anamika |
author_sort | Kausar, Mohd Adnan |
collection | PubMed |
description | Dengue is a viral infection caused by RNA infection of the family Flaviviridae and spread by the Aedes mosquitoes. Dengue NS5 methyltransferase is a known drug target for the disease. Therefore, it is of interest to design potential inhibitors for the target using molecular docking analysis. Our analysis shows the binding of compounds STOCK1N-98943, STOCK1N-98872, STOCK1N-98956, STOCK1N-98865, and STOCK1N-98950 with the protein drug target with optimal binding features for further in vitro and in vivo evaluations. |
format | Online Article Text |
id | pubmed-6614123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Biomedical Informatics |
record_format | MEDLINE/PubMed |
spelling | pubmed-66141232019-07-16 Molecular docking based design of Dengue NS5 methyltransferase inhibitors Kausar, Mohd Adnan Ali, Abrar Qiblawi, Samir Shahid, SMA Izhari, Mohammad Asrar saral, Anamika Bioinformation Research Article Dengue is a viral infection caused by RNA infection of the family Flaviviridae and spread by the Aedes mosquitoes. Dengue NS5 methyltransferase is a known drug target for the disease. Therefore, it is of interest to design potential inhibitors for the target using molecular docking analysis. Our analysis shows the binding of compounds STOCK1N-98943, STOCK1N-98872, STOCK1N-98956, STOCK1N-98865, and STOCK1N-98950 with the protein drug target with optimal binding features for further in vitro and in vivo evaluations. Biomedical Informatics 2019-05-30 /pmc/articles/PMC6614123/ /pubmed/31312076 http://dx.doi.org/10.6026/97320630015394 Text en © 2019 Biomedical Informatics http://creativecommons.org/licenses/by/3.0/ This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License. |
spellingShingle | Research Article Kausar, Mohd Adnan Ali, Abrar Qiblawi, Samir Shahid, SMA Izhari, Mohammad Asrar saral, Anamika Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title | Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title_full | Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title_fullStr | Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title_full_unstemmed | Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title_short | Molecular docking based design of Dengue NS5 methyltransferase inhibitors |
title_sort | molecular docking based design of dengue ns5 methyltransferase inhibitors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614123/ https://www.ncbi.nlm.nih.gov/pubmed/31312076 http://dx.doi.org/10.6026/97320630015394 |
work_keys_str_mv | AT kausarmohdadnan moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors AT aliabrar moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors AT qiblawisamir moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors AT shahidsma moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors AT izharimohammadasrar moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors AT saralanamika moleculardockingbaseddesignofdenguens5methyltransferaseinhibitors |